Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Henoch-Schönlein purpura.

B Duquesnoy

    Bailliere'S Clinical Rheumatology
    |August 1, 1991
    PubMed
    Summary
    This summary is machine-generated.

    Henoch-Schönlein purpura is likely caused by an infection triggering an immune response. This leads to IgA vasculitis with kidney and skin symptoms, but causes remain unclear.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Anorexia nervosa, osteoporosis and circulating leptin: the missing link.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2010
    Same author

    [Multicenter multidisciplinary training program for chronic low back pain: French experience of the Renodos back pain network (Réseau Nord-Pas-de-Calais du DOS)].

    Annals of physical and rehabilitation medicine·2009
    Same author

    Quality of sleep in patients with chronic low back pain: a case-control study.

    European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·2008
    Same author

    [Isokinetic trunk strength testing in chronic low back pain. The role of habituation and training to improve measures].

    Annales de readaptation et de medecine physique : revue scientifique de la Societe francaise de reeducation fonctionnelle de readaptation et de medecine physique·2007
    Same author

    Lack of efficacy of a third tumour necrosis factor alpha antagonist after failure of a soluble receptor and a monoclonal antibody.

    Rheumatology (Oxford, England)·2006
    Same author

    The usefulness of bone remodelling markers in predicting the efficacy of pamidronate treatment in SAPHO syndrome.

    Rheumatology (Oxford, England)·2005
    Same journal

    Regional soft tissue pains: alias myofascial pain?

    Bailliere's clinical rheumatology·1999
    Same journal

    The knee

    Bailliere's clinical rheumatology·1999
    Same journal

    The elbow, forearm, wrist and hand

    Bailliere's clinical rheumatology·1999
    Same journal

    Shoulder disorders: a state-of-the-art review

    Bailliere's clinical rheumatology·1999
    Same journal

    The neck

    Bailliere's clinical rheumatology·1999
    Same journal

    Treatment options for regional musculoskeletal pain: what is the evidence?

    Bailliere's clinical rheumatology·1999
    See all related articles

    Area of Science:

    • Immunology
    • Nephrology
    • Dermatology

    Background:

    • Henoch-Schönlein purpura (HSP) is a systemic vasculitis characterized by IgA deposition.
    • It commonly affects the skin, joints, gastrointestinal tract, and kidneys.

    Purpose of the Study:

    • To review the current understanding of Henoch-Schönlein purpura pathogenesis.
    • To highlight the association between HSP and IgA nephropathy.

    Main Methods:

    • Literature review of studies on HSP.
    • Analysis of immunological and clinical data related to HSP.

    Main Results:

    • HSP is believed to arise from an immune response to an infective trigger.
    • Immune complexes containing IgA antibodies lead to leukoclastic vasculitis.
  • Renal and dermatological manifestations are key features of HSP.

    • Conclusions:

    • The precise risk factors and causative agents for HSP are not fully understood.
    • The underlying reasons for the link between HSP and IgA nephropathy require further investigation.